bpc-157 mast cell activation Cell–Targeting Therapies in Mast Syndromes | Current Allergy and Asthma Reports Mast Cell Activation Syndrome MCAS

Your body naturally produces them, and they act as messengers that help regulate key functions like metabolism, appetite, and blood sugar

Developed by Eli Lilly, it is a single-molecule triple receptor agonist targeting three key metabolic hormone receptors simultaneously: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon

BPC-157 can survive the digestive environment and interact with cells in the gastrointestinal tract, promoting mucosal repair, angiogenesis, and anti-inflammatory effects that accelerate healing of ulcers, lesions, and intestinal injuries when administered orally

10.1016/j.bbr.2014.08.002 206

This compounds across multiple exposures, which is why strict cold chain discipline matters from the moment of reconstitution